The Oxford University spin-out set up by its technology transfer office raises the funds at the same time as winning a development award from the UK's National Health Service.

Mexico-based healthcare company Grupo Vitalmex invests $2m in US-based cell technology company Bioheart.

Academic medical centre Cleveland Clinic has partnered up with healthcare organisation ProMedica to deliver higher quality healthcare.

Gene therapy specialist Bluebird Bio raises $60m in a Series D financing round, backed by UK and US-listed pharmaceutical company Shire.

OvaScience, a US-based fertility company, has raised $37m in its series B round.

CytomX, which develops antibodies, previously raised $5m in its series A from angels, according to news provider VentureWire.